Mechanism of cartilage destruction in osteoarthritis
- PMID: 12580533
Mechanism of cartilage destruction in osteoarthritis
Abstract
Osteoarthritis (OA) is one of the most common diseases among the elderly. For many years, OA was considered a normal result of the aging process with few treatment options. Remarkable progress in understanding OA cartilage has been achieved in recent years. The application of technical advances to clinical studies of chondrocytes and cartilage tissue metabolism will provide important new insights concerning the pathophysiology of OA and identify new therapeutic strategies to regulate and inhibit the degenerative process of OA. However, many problems remain unresolved. In this review we try to focus on recent advances in the field of cartilage metabolism and molecular markers to facilitate the determination of a patients prognosis and the need for cartilage protective treatment.
Similar articles
-
The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.J Rheumatol Suppl. 1995 Feb;43:75-7. J Rheumatol Suppl. 1995. PMID: 7752145
-
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.Arthritis Rheum. 2003 Nov;48(11):3085-95. doi: 10.1002/art.11331. Arthritis Rheum. 2003. PMID: 14613270
-
The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.Arthritis Rheum. 2003 May;48(5):1261-70. doi: 10.1002/art.10976. Arthritis Rheum. 2003. PMID: 12746899
-
Aggrecan degradation in osteoarthritis and rheumatoid arthritis.Acta Orthop Scand Suppl. 1995 Oct;266:92-7. Acta Orthop Scand Suppl. 1995. PMID: 8553869 Review. No abstract available.
-
Keratan sulfate in body fluids in joint disease.Acta Orthop Scand Suppl. 1995 Oct;266:103-6. Acta Orthop Scand Suppl. 1995. PMID: 8553836 Review. No abstract available.
Cited by
-
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).J Transl Med. 2016 Aug 26;14(1):246. doi: 10.1186/s12967-016-0998-2. J Transl Med. 2016. PMID: 27565858 Free PMC article. Clinical Trial.
-
Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture.BMC Musculoskelet Disord. 2013 Aug 9;14:235. doi: 10.1186/1471-2474-14-235. BMC Musculoskelet Disord. 2013. PMID: 23937653 Free PMC article.
-
Interleukin-10 and collagen type II immunoexpression are modulated by photobiomodulation associated to aerobic and aquatic exercises in an experimental model of osteoarthritis.Lasers Med Sci. 2018 Dec;33(9):1875-1882. doi: 10.1007/s10103-018-2541-6. Epub 2018 May 24. Lasers Med Sci. 2018. PMID: 29797102
-
Potential metabolites of Arecaceae family for the natural anti-osteoarthritis medicine: A review.Heliyon. 2022 Dec 6;8(12):e12039. doi: 10.1016/j.heliyon.2022.e12039. eCollection 2022 Dec. Heliyon. 2022. PMID: 36561673 Free PMC article. Review.
-
Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis.Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3342-3350. doi: 10.1007/s00167-018-4883-9. Epub 2018 Mar 6. Knee Surg Sports Traumatol Arthrosc. 2018. PMID: 29511819 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical